Women's Health Industry Research Report 2023
This report focuses on pharmaceutical products for female-related diseases.
Highlights
The global Women's Health market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Women's Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women's Health.
The Women's Health market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Women's Health market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women's Health companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Women's Health type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Women's Health are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Women's Health segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Women's Health market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Women's Health market.
Women's Health Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Women's Health market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Women's Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Women's Health industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Women's Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Highlights
The global Women's Health market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Women's Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women's Health.
The Women's Health market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Women's Health market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women's Health companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Amgen
- Bayer
- Merck KGaA
- Merck & Co
- Ferring
- Eli Lilly
- Pfizer
- AbbVie
- Abbott
- Theramex
- Livzon Pharmaceutical Group
- Foundation Consumer Healthcare
- Zhejiang Xianju Pharmaceutical
- Zizhu Pharmaceutical
- Qianjin Pharmaceutical
Global markets are presented by Women's Health type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Women's Health are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Women's Health segment by Type
- Hormone Therapy
- Nonhormonal Therapy
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Women's Health market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Women's Health market.
Women's Health Segment by Application
- Climacteric
- Postmenopausal Osteoporosis
- Contraceptive Pill
- Infertility
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Women's Health market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Women's Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Women's Health industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Women's Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Women's Health by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Hormone Therapy
1.2.3 Nonhormonal Therapy
2.3 Women's Health by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Climacteric
2.3.3 Postmenopausal Osteoporosis
2.3.4 Contraceptive Pill
2.3.5 Infertility
2.3.6 Others
2.4 Assumptions and Limitations
3 WOMEN'S HEALTH BREAKDOWN DATA BY TYPE
3.1 Global Women's Health Historic Market Size by Type (2018-2023)
3.2 Global Women's Health Forecasted Market Size by Type (2023-2028)
4 WOMEN'S HEALTH BREAKDOWN DATA BY APPLICATION
4.1 Global Women's Health Historic Market Size by Application (2018-2023)
4.2 Global Women's Health Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Women's Health Market Perspective (2018-2029)
5.2 Global Women's Health Growth Trends by Region
5.2.1 Global Women's Health Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Women's Health Historic Market Size by Region (2018-2023)
5.2.3 Women's Health Forecasted Market Size by Region (2024-2029)
5.3 Women's Health Market Dynamics
5.3.1 Women's Health Industry Trends
5.3.2 Women's Health Market Drivers
5.3.3 Women's Health Market Challenges
5.3.4 Women's Health Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Women's Health Players by Revenue
6.1.1 Global Top Women's Health Players by Revenue (2018-2023)
6.1.2 Global Women's Health Revenue Market Share by Players (2018-2023)
6.2 Global Women's Health Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Women's Health Head office and Area Served
6.4 Global Women's Health Players, Product Type & Application
6.5 Global Women's Health Players, Date of Enter into This Industry
6.6 Global Women's Health Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Women's Health Market Size (2018-2029)
7.2 North America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Women's Health Market Size by Country (2018-2023)
7.4 North America Women's Health Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Women's Health Market Size (2018-2029)
8.2 Europe Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Women's Health Market Size by Country (2018-2023)
8.4 Europe Women's Health Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Women's Health Market Size (2018-2029)
9.2 Asia-Pacific Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Women's Health Market Size by Country (2018-2023)
9.4 Asia-Pacific Women's Health Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Women's Health Market Size (2018-2029)
10.2 Latin America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Women's Health Market Size by Country (2018-2023)
10.4 Latin America Women's Health Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Women's Health Market Size (2018-2029)
11.2 Middle East & Africa Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Women's Health Market Size by Country (2018-2023)
11.4 Middle East & Africa Women's Health Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Women's Health Introduction
11.1.4 Amgen Revenue in Women's Health Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Women's Health Introduction
11.2.4 Bayer Revenue in Women's Health Business (2017-2022)
11.2.5 Bayer Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Women's Health Introduction
11.3.4 Merck KGaA Revenue in Women's Health Business (2017-2022)
11.3.5 Merck KGaA Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Detail
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Women's Health Introduction
11.4.4 Merck & Co Revenue in Women's Health Business (2017-2022)
11.4.5 Merck & Co Recent Development
11.5 Ferring
11.5.1 Ferring Company Detail
11.5.2 Ferring Business Overview
11.5.3 Ferring Women's Health Introduction
11.5.4 Ferring Revenue in Women's Health Business (2017-2022)
11.5.5 Ferring Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Women's Health Introduction
11.6.4 Eli Lilly Revenue in Women's Health Business (2017-2022)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Women's Health Introduction
11.7.4 Pfizer Revenue in Women's Health Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Women's Health Introduction
11.8.4 AbbVie Revenue in Women's Health Business (2017-2022)
11.8.5 AbbVie Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Women's Health Introduction
11.9.4 Abbott Revenue in Women's Health Business (2017-2022)
11.9.5 Abbott Recent Development
11.10 Theramex
11.10.1 Theramex Company Detail
11.10.2 Theramex Business Overview
11.10.3 Theramex Women's Health Introduction
11.10.4 Theramex Revenue in Women's Health Business (2017-2022)
11.10.5 Theramex Recent Development
11.11 Livzon Pharmaceutical Group
11.11.1 Livzon Pharmaceutical Group Company Detail
11.11.2 Livzon Pharmaceutical Group Business Overview
11.11.3 Livzon Pharmaceutical Group Women's Health Introduction
11.11.4 Livzon Pharmaceutical Group Revenue in Women's Health Business (2017-2022)
11.11.5 Livzon Pharmaceutical Group Recent Development
11.12 Foundation Consumer Healthcare
11.12.1 Foundation Consumer Healthcare Company Detail
11.12.2 Foundation Consumer Healthcare Business Overview
11.12.3 Foundation Consumer Healthcare Women's Health Introduction
11.12.4 Foundation Consumer Healthcare Revenue in Women's Health Business (2017-2022)
11.12.5 Foundation Consumer Healthcare Recent Development
11.13 Zhejiang Xianju Pharmaceutical
11.13.1 Zhejiang Xianju Pharmaceutical Company Detail
11.13.2 Zhejiang Xianju Pharmaceutical Business Overview
11.13.3 Zhejiang Xianju Pharmaceutical Women's Health Introduction
11.13.4 Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2017-2022)
11.13.5 Zhejiang Xianju Pharmaceutical Recent Development
11.14 Zizhu Pharmaceutical
11.14.1 Zizhu Pharmaceutical Company Detail
11.14.2 Zizhu Pharmaceutical Business Overview
11.14.3 Zizhu Pharmaceutical Women's Health Introduction
11.14.4 Zizhu Pharmaceutical Revenue in Women's Health Business (2017-2022)
11.14.5 Zizhu Pharmaceutical Recent Development
11.15 Qianjin Pharmaceutical
11.15.1 Qianjin Pharmaceutical Company Detail
11.15.2 Qianjin Pharmaceutical Business Overview
11.15.3 Qianjin Pharmaceutical Women's Health Introduction
11.15.4 Qianjin Pharmaceutical Revenue in Women's Health Business (2017-2022)
11.15.5 Qianjin Pharmaceutical Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Women's Health by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Hormone Therapy
1.2.3 Nonhormonal Therapy
2.3 Women's Health by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Climacteric
2.3.3 Postmenopausal Osteoporosis
2.3.4 Contraceptive Pill
2.3.5 Infertility
2.3.6 Others
2.4 Assumptions and Limitations
3 WOMEN'S HEALTH BREAKDOWN DATA BY TYPE
3.1 Global Women's Health Historic Market Size by Type (2018-2023)
3.2 Global Women's Health Forecasted Market Size by Type (2023-2028)
4 WOMEN'S HEALTH BREAKDOWN DATA BY APPLICATION
4.1 Global Women's Health Historic Market Size by Application (2018-2023)
4.2 Global Women's Health Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Women's Health Market Perspective (2018-2029)
5.2 Global Women's Health Growth Trends by Region
5.2.1 Global Women's Health Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Women's Health Historic Market Size by Region (2018-2023)
5.2.3 Women's Health Forecasted Market Size by Region (2024-2029)
5.3 Women's Health Market Dynamics
5.3.1 Women's Health Industry Trends
5.3.2 Women's Health Market Drivers
5.3.3 Women's Health Market Challenges
5.3.4 Women's Health Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Women's Health Players by Revenue
6.1.1 Global Top Women's Health Players by Revenue (2018-2023)
6.1.2 Global Women's Health Revenue Market Share by Players (2018-2023)
6.2 Global Women's Health Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Women's Health Head office and Area Served
6.4 Global Women's Health Players, Product Type & Application
6.5 Global Women's Health Players, Date of Enter into This Industry
6.6 Global Women's Health Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Women's Health Market Size (2018-2029)
7.2 North America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Women's Health Market Size by Country (2018-2023)
7.4 North America Women's Health Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Women's Health Market Size (2018-2029)
8.2 Europe Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Women's Health Market Size by Country (2018-2023)
8.4 Europe Women's Health Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Women's Health Market Size (2018-2029)
9.2 Asia-Pacific Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Women's Health Market Size by Country (2018-2023)
9.4 Asia-Pacific Women's Health Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Women's Health Market Size (2018-2029)
10.2 Latin America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Women's Health Market Size by Country (2018-2023)
10.4 Latin America Women's Health Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Women's Health Market Size (2018-2029)
11.2 Middle East & Africa Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Women's Health Market Size by Country (2018-2023)
11.4 Middle East & Africa Women's Health Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Women's Health Introduction
11.1.4 Amgen Revenue in Women's Health Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Women's Health Introduction
11.2.4 Bayer Revenue in Women's Health Business (2017-2022)
11.2.5 Bayer Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Women's Health Introduction
11.3.4 Merck KGaA Revenue in Women's Health Business (2017-2022)
11.3.5 Merck KGaA Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Detail
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Women's Health Introduction
11.4.4 Merck & Co Revenue in Women's Health Business (2017-2022)
11.4.5 Merck & Co Recent Development
11.5 Ferring
11.5.1 Ferring Company Detail
11.5.2 Ferring Business Overview
11.5.3 Ferring Women's Health Introduction
11.5.4 Ferring Revenue in Women's Health Business (2017-2022)
11.5.5 Ferring Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Women's Health Introduction
11.6.4 Eli Lilly Revenue in Women's Health Business (2017-2022)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Women's Health Introduction
11.7.4 Pfizer Revenue in Women's Health Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Women's Health Introduction
11.8.4 AbbVie Revenue in Women's Health Business (2017-2022)
11.8.5 AbbVie Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Women's Health Introduction
11.9.4 Abbott Revenue in Women's Health Business (2017-2022)
11.9.5 Abbott Recent Development
11.10 Theramex
11.10.1 Theramex Company Detail
11.10.2 Theramex Business Overview
11.10.3 Theramex Women's Health Introduction
11.10.4 Theramex Revenue in Women's Health Business (2017-2022)
11.10.5 Theramex Recent Development
11.11 Livzon Pharmaceutical Group
11.11.1 Livzon Pharmaceutical Group Company Detail
11.11.2 Livzon Pharmaceutical Group Business Overview
11.11.3 Livzon Pharmaceutical Group Women's Health Introduction
11.11.4 Livzon Pharmaceutical Group Revenue in Women's Health Business (2017-2022)
11.11.5 Livzon Pharmaceutical Group Recent Development
11.12 Foundation Consumer Healthcare
11.12.1 Foundation Consumer Healthcare Company Detail
11.12.2 Foundation Consumer Healthcare Business Overview
11.12.3 Foundation Consumer Healthcare Women's Health Introduction
11.12.4 Foundation Consumer Healthcare Revenue in Women's Health Business (2017-2022)
11.12.5 Foundation Consumer Healthcare Recent Development
11.13 Zhejiang Xianju Pharmaceutical
11.13.1 Zhejiang Xianju Pharmaceutical Company Detail
11.13.2 Zhejiang Xianju Pharmaceutical Business Overview
11.13.3 Zhejiang Xianju Pharmaceutical Women's Health Introduction
11.13.4 Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2017-2022)
11.13.5 Zhejiang Xianju Pharmaceutical Recent Development
11.14 Zizhu Pharmaceutical
11.14.1 Zizhu Pharmaceutical Company Detail
11.14.2 Zizhu Pharmaceutical Business Overview
11.14.3 Zizhu Pharmaceutical Women's Health Introduction
11.14.4 Zizhu Pharmaceutical Revenue in Women's Health Business (2017-2022)
11.14.5 Zizhu Pharmaceutical Recent Development
11.15 Qianjin Pharmaceutical
11.15.1 Qianjin Pharmaceutical Company Detail
11.15.2 Qianjin Pharmaceutical Business Overview
11.15.3 Qianjin Pharmaceutical Women's Health Introduction
11.15.4 Qianjin Pharmaceutical Revenue in Women's Health Business (2017-2022)
11.15.5 Qianjin Pharmaceutical Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Women's Health Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Women's Health Revenue Market Share by Type (2018-2023)
Table 7. Global Women's Health Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Women's Health Revenue Market Share by Type (2024-2029)
Table 9. Global Women's Health Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Women's Health Revenue Market Share by Application (2018-2023)
Table 11. Global Women's Health Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Women's Health Revenue Market Share by Application (2024-2029)
Table 13. Global Women's Health Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Women's Health Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Women's Health Market Share by Region (2018-2023)
Table 16. Global Women's Health Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Women's Health Market Share by Region (2024-2029)
Table 18. Women's Health Market Trends
Table 19. Women's Health Market Drivers
Table 20. Women's Health Market Challenges
Table 21. Women's Health Market Restraints
Table 22. Global Top Women's Health Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Women's Health Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Women's Health Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Women's Health, Headquarters and Area Served
Table 26. Global Women's Health Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Women's Health by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 45. Amgen Company Detail
Table 46. Amgen Business Overview
Table 47. Amgen Women's Health Product
Table 48. Amgen Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 49. Amgen Recent Development
Table 50. Bayer Company Detail
Table 51. Bayer Business Overview
Table 52. Bayer Women's Health Product
Table 53. Bayer Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. Merck KGaA Company Detail
Table 56. Merck KGaA Business Overview
Table 57. Merck KGaA Women's Health Product
Table 58. Merck KGaA Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 59. Merck KGaA Recent Development
Table 60. Merck & Co Company Detail
Table 61. Merck & Co Business Overview
Table 62. Merck & Co Women's Health Product
Table 63. Merck & Co Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 64. Merck & Co Recent Development
Table 65. Ferring Company Detail
Table 66. Ferring Business Overview
Table 67. Ferring Women's Health Product
Table 68. Ferring Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 69. Ferring Recent Development
Table 70. Eli Lilly Company Detail
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly Women's Health Product
Table 73. Eli Lilly Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 74. Eli Lilly Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Women's Health Product
Table 78. Pfizer Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. AbbVie Company Detail
Table 81. AbbVie Business Overview
Table 82. AbbVie Women's Health Product
Table 83. AbbVie Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 84. AbbVie Recent Development
Table 85. Abbott Company Detail
Table 86. Abbott Business Overview
Table 87. Abbott Women's Health Product
Table 88. Abbott Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 89. Abbott Recent Development
Table 90. Theramex Company Detail
Table 91. Theramex Business Overview
Table 92. Theramex Women's Health Product
Table 93. Theramex Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 94. Theramex Recent Development
Table 95. Livzon Pharmaceutical Group Company Detail
Table 96. Livzon Pharmaceutical Group Business Overview
Table 97. Livzon Pharmaceutical Group Women's HealthProduct
Table 98. Livzon Pharmaceutical Group Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 99. Livzon Pharmaceutical Group Recent Development
Table 100. Foundation Consumer Healthcare Company Detail
Table 101. Foundation Consumer Healthcare Business Overview
Table 102. Foundation Consumer Healthcare Women's HealthProduct
Table 103. Foundation Consumer Healthcare Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 104. Foundation Consumer Healthcare Recent Development
Table 105. Zhejiang Xianju Pharmaceutical Company Detail
Table 106. Zhejiang Xianju Pharmaceutical Business Overview
Table 107. Zhejiang Xianju Pharmaceutical Women's HealthProduct
Table 108. Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 109. Zhejiang Xianju Pharmaceutical Recent Development
Table 110. Zizhu Pharmaceutical Company Detail
Table 111. Zizhu Pharmaceutical Business Overview
Table 112. Zizhu Pharmaceutical Women's HealthProduct
Table 113. Zizhu Pharmaceutical Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 114. Zizhu Pharmaceutical Recent Development
Table 115. Qianjin Pharmaceutical Company Detail
Table 116. Qianjin Pharmaceutical Business Overview
Table 117. Qianjin Pharmaceutical Women's HealthProduct
Table 118. Qianjin Pharmaceutical Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 119. Qianjin Pharmaceutical Recent Development
Table 120. Amgen Company Information
Table 121. Amgen Business Overview
Table 122. Amgen Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 123. Amgen Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 124. Amgen Recent Development
Table 125. Bayer Company Information
Table 126. Bayer Business Overview
Table 127. Bayer Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 128. Bayer Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bayer Recent Development
Table 130. Merck KGaA Company Information
Table 131. Merck KGaA Business Overview
Table 132. Merck KGaA Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 133. Merck KGaA Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 134. Merck KGaA Recent Development
Table 135. Merck & Co Company Information
Table 136. Merck & Co Business Overview
Table 137. Merck & Co Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 138. Merck & Co Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 139. Merck & Co Recent Development
Table 140. Ferring Company Information
Table 141. Ferring Business Overview
Table 142. Ferring Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 143. Ferring Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 144. Ferring Recent Development
Table 145. Eli Lilly Company Information
Table 146. Eli Lilly Business Overview
Table 147. Eli Lilly Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 148. Eli Lilly Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 149. Eli Lilly Recent Development
Table 150. Pfizer Company Information
Table 151. Pfizer Business Overview
Table 152. Pfizer Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 153. Pfizer Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 154. Pfizer Recent Development
Table 155. AbbVie Company Information
Table 156. AbbVie Business Overview
Table 157. AbbVie Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 158. AbbVie Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 159. AbbVie Recent Development
Table 160. Abbott Company Information
Table 161. Abbott Business Overview
Table 162. Abbott Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 163. Abbott Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 164. Abbott Recent Development
Table 165. Theramex Company Information
Table 166. Theramex Business Overview
Table 167. Theramex Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 168. Theramex Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 169. Theramex Recent Development
Table 170. Livzon Pharmaceutical Group Company Information
Table 171. Livzon Pharmaceutical Group Business Overview
Table 172. Livzon Pharmaceutical Group Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 173. Livzon Pharmaceutical Group Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 174. Livzon Pharmaceutical Group Recent Development
Table 175. Foundation Consumer Healthcare Company Information
Table 176. Foundation Consumer Healthcare Business Overview
Table 177. Foundation Consumer Healthcare Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 178. Foundation Consumer Healthcare Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 179. Foundation Consumer Healthcare Recent Development
Table 180. Zhejiang Xianju Pharmaceutical Company Information
Table 181. Zhejiang Xianju Pharmaceutical Business Overview
Table 182. Zhejiang Xianju Pharmaceutical Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 183. Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 184. Zhejiang Xianju Pharmaceutical Recent Development
Table 185. Zizhu Pharmaceutical Company Information
Table 186. Zizhu Pharmaceutical Business Overview
Table 187. Zizhu Pharmaceutical Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 188. Zizhu Pharmaceutical Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 189. Zizhu Pharmaceutical Recent Development
Table 190. Qianjin Pharmaceutical Company Information
Table 191. Qianjin Pharmaceutical Business Overview
Table 192. Qianjin Pharmaceutical Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 193. Qianjin Pharmaceutical Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 194. Qianjin Pharmaceutical Recent Development
Table 195. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Women's Health Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Women's Health Revenue Market Share by Type (2018-2023)
Table 7. Global Women's Health Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Women's Health Revenue Market Share by Type (2024-2029)
Table 9. Global Women's Health Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Women's Health Revenue Market Share by Application (2018-2023)
Table 11. Global Women's Health Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Women's Health Revenue Market Share by Application (2024-2029)
Table 13. Global Women's Health Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Women's Health Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Women's Health Market Share by Region (2018-2023)
Table 16. Global Women's Health Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Women's Health Market Share by Region (2024-2029)
Table 18. Women's Health Market Trends
Table 19. Women's Health Market Drivers
Table 20. Women's Health Market Challenges
Table 21. Women's Health Market Restraints
Table 22. Global Top Women's Health Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Women's Health Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Women's Health Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Women's Health, Headquarters and Area Served
Table 26. Global Women's Health Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Women's Health by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Women's Health Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Women's Health Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Women's Health Market Size by Country (2024-2029) & (US$ Million)
Table 45. Amgen Company Detail
Table 46. Amgen Business Overview
Table 47. Amgen Women's Health Product
Table 48. Amgen Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 49. Amgen Recent Development
Table 50. Bayer Company Detail
Table 51. Bayer Business Overview
Table 52. Bayer Women's Health Product
Table 53. Bayer Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. Merck KGaA Company Detail
Table 56. Merck KGaA Business Overview
Table 57. Merck KGaA Women's Health Product
Table 58. Merck KGaA Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 59. Merck KGaA Recent Development
Table 60. Merck & Co Company Detail
Table 61. Merck & Co Business Overview
Table 62. Merck & Co Women's Health Product
Table 63. Merck & Co Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 64. Merck & Co Recent Development
Table 65. Ferring Company Detail
Table 66. Ferring Business Overview
Table 67. Ferring Women's Health Product
Table 68. Ferring Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 69. Ferring Recent Development
Table 70. Eli Lilly Company Detail
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly Women's Health Product
Table 73. Eli Lilly Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 74. Eli Lilly Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Women's Health Product
Table 78. Pfizer Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. AbbVie Company Detail
Table 81. AbbVie Business Overview
Table 82. AbbVie Women's Health Product
Table 83. AbbVie Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 84. AbbVie Recent Development
Table 85. Abbott Company Detail
Table 86. Abbott Business Overview
Table 87. Abbott Women's Health Product
Table 88. Abbott Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 89. Abbott Recent Development
Table 90. Theramex Company Detail
Table 91. Theramex Business Overview
Table 92. Theramex Women's Health Product
Table 93. Theramex Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 94. Theramex Recent Development
Table 95. Livzon Pharmaceutical Group Company Detail
Table 96. Livzon Pharmaceutical Group Business Overview
Table 97. Livzon Pharmaceutical Group Women's HealthProduct
Table 98. Livzon Pharmaceutical Group Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 99. Livzon Pharmaceutical Group Recent Development
Table 100. Foundation Consumer Healthcare Company Detail
Table 101. Foundation Consumer Healthcare Business Overview
Table 102. Foundation Consumer Healthcare Women's HealthProduct
Table 103. Foundation Consumer Healthcare Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 104. Foundation Consumer Healthcare Recent Development
Table 105. Zhejiang Xianju Pharmaceutical Company Detail
Table 106. Zhejiang Xianju Pharmaceutical Business Overview
Table 107. Zhejiang Xianju Pharmaceutical Women's HealthProduct
Table 108. Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 109. Zhejiang Xianju Pharmaceutical Recent Development
Table 110. Zizhu Pharmaceutical Company Detail
Table 111. Zizhu Pharmaceutical Business Overview
Table 112. Zizhu Pharmaceutical Women's HealthProduct
Table 113. Zizhu Pharmaceutical Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 114. Zizhu Pharmaceutical Recent Development
Table 115. Qianjin Pharmaceutical Company Detail
Table 116. Qianjin Pharmaceutical Business Overview
Table 117. Qianjin Pharmaceutical Women's HealthProduct
Table 118. Qianjin Pharmaceutical Revenue in Women's Health Business (2017-2022) & (US$ Million)
Table 119. Qianjin Pharmaceutical Recent Development
Table 120. Amgen Company Information
Table 121. Amgen Business Overview
Table 122. Amgen Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 123. Amgen Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 124. Amgen Recent Development
Table 125. Bayer Company Information
Table 126. Bayer Business Overview
Table 127. Bayer Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 128. Bayer Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bayer Recent Development
Table 130. Merck KGaA Company Information
Table 131. Merck KGaA Business Overview
Table 132. Merck KGaA Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 133. Merck KGaA Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 134. Merck KGaA Recent Development
Table 135. Merck & Co Company Information
Table 136. Merck & Co Business Overview
Table 137. Merck & Co Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 138. Merck & Co Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 139. Merck & Co Recent Development
Table 140. Ferring Company Information
Table 141. Ferring Business Overview
Table 142. Ferring Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 143. Ferring Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 144. Ferring Recent Development
Table 145. Eli Lilly Company Information
Table 146. Eli Lilly Business Overview
Table 147. Eli Lilly Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 148. Eli Lilly Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 149. Eli Lilly Recent Development
Table 150. Pfizer Company Information
Table 151. Pfizer Business Overview
Table 152. Pfizer Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 153. Pfizer Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 154. Pfizer Recent Development
Table 155. AbbVie Company Information
Table 156. AbbVie Business Overview
Table 157. AbbVie Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 158. AbbVie Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 159. AbbVie Recent Development
Table 160. Abbott Company Information
Table 161. Abbott Business Overview
Table 162. Abbott Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 163. Abbott Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 164. Abbott Recent Development
Table 165. Theramex Company Information
Table 166. Theramex Business Overview
Table 167. Theramex Women's Health Revenue in Women's Health Business (2018-2023) & (US$ Million)
Table 168. Theramex Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 169. Theramex Recent Development
Table 170. Livzon Pharmaceutical Group Company Information
Table 171. Livzon Pharmaceutical Group Business Overview
Table 172. Livzon Pharmaceutical Group Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 173. Livzon Pharmaceutical Group Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 174. Livzon Pharmaceutical Group Recent Development
Table 175. Foundation Consumer Healthcare Company Information
Table 176. Foundation Consumer Healthcare Business Overview
Table 177. Foundation Consumer Healthcare Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 178. Foundation Consumer Healthcare Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 179. Foundation Consumer Healthcare Recent Development
Table 180. Zhejiang Xianju Pharmaceutical Company Information
Table 181. Zhejiang Xianju Pharmaceutical Business Overview
Table 182. Zhejiang Xianju Pharmaceutical Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 183. Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 184. Zhejiang Xianju Pharmaceutical Recent Development
Table 185. Zizhu Pharmaceutical Company Information
Table 186. Zizhu Pharmaceutical Business Overview
Table 187. Zizhu Pharmaceutical Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 188. Zizhu Pharmaceutical Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 189. Zizhu Pharmaceutical Recent Development
Table 190. Qianjin Pharmaceutical Company Information
Table 191. Qianjin Pharmaceutical Business Overview
Table 192. Qianjin Pharmaceutical Women's HealthRevenue in Women's Health Business (2018-2023) & (US$ Million)
Table 193. Qianjin Pharmaceutical Revenue in Women's Health Business (2018-2023) & (US$ Million) Portfolio
Table 194. Qianjin Pharmaceutical Recent Development
Table 195. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Women's Health Product Picture
Figure 5. Global Women's Health Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Women's Health Market Share by Type: 2022 VS 2029
Figure 7. Hormone Therapy Product Picture
Figure 8. Nonhormonal Therapy Product Picture
Figure 9. Global Women's Health Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Women's Health Market Share by Application: 2022 VS 2029
Figure 11. Climacteric Product Picture
Figure 12. Postmenopausal Osteoporosis Product Picture
Figure 13. Contraceptive Pill Product Picture
Figure 14. Infertility Product Picture
Figure 15. Others Product Picture
Figure 16. Global Women's Health Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Women's Health Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Women's Health Market Share by Region: 2022 VS 2029
Figure 19. Global Women's Health Market Share by Players in 2022
Figure 20. Global Women's Health Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Women's Health Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Women's Health Market Share by Country (2018-2029)
Figure 25. United States Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Women's Health Market Share by Country (2018-2029)
Figure 29. Germany Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Women's Health Market Share by Country (2018-2029)
Figure 37. China Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Women's Health Market Share by Country (2018-2029)
Figure 45. Mexico Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Women's Health Market Share by Country (2018-2029)
Figure 49. Turkey Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Amgen Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 54. Merck KGaA Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 55. Merck & Co Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 56. Ferring Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 57. Eli Lilly Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 59. AbbVie Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 60. Abbott Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 61. Theramex Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 62. Livzon Pharmaceutical Group Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 63. Foundation Consumer Healthcare Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 64. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 65. Zizhu Pharmaceutical Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 66. Qianjin Pharmaceutical Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Women's Health Product Picture
Figure 5. Global Women's Health Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Women's Health Market Share by Type: 2022 VS 2029
Figure 7. Hormone Therapy Product Picture
Figure 8. Nonhormonal Therapy Product Picture
Figure 9. Global Women's Health Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Women's Health Market Share by Application: 2022 VS 2029
Figure 11. Climacteric Product Picture
Figure 12. Postmenopausal Osteoporosis Product Picture
Figure 13. Contraceptive Pill Product Picture
Figure 14. Infertility Product Picture
Figure 15. Others Product Picture
Figure 16. Global Women's Health Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Women's Health Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Women's Health Market Share by Region: 2022 VS 2029
Figure 19. Global Women's Health Market Share by Players in 2022
Figure 20. Global Women's Health Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Women's Health Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Women's Health Market Share by Country (2018-2029)
Figure 25. United States Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Women's Health Market Share by Country (2018-2029)
Figure 29. Germany Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Women's Health Market Share by Country (2018-2029)
Figure 37. China Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Women's Health Market Share by Country (2018-2029)
Figure 45. Mexico Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Women's Health Market Share by Country (2018-2029)
Figure 49. Turkey Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Women's Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Amgen Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 54. Merck KGaA Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 55. Merck & Co Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 56. Ferring Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 57. Eli Lilly Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 59. AbbVie Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 60. Abbott Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 61. Theramex Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 62. Livzon Pharmaceutical Group Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 63. Foundation Consumer Healthcare Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 64. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 65. Zizhu Pharmaceutical Revenue Growth Rate in Women's Health Business (2018-2023)
Figure 66. Qianjin Pharmaceutical Revenue Growth Rate in Women's Health Business (2018-2023)
